Apeiron Biologics - Ownership and Business Overview

Life ScienceCompany

Apeiron Biologics Ownership

Who owns Apeiron Biologics?

Apeiron Biologics is owned by Ligand Pharmaceuticals. It was acquired on July 8, 2024.

Apeiron Biologics Business Overview

Where is Apeiron Biologics headquartered?

Apeiron Biologics is headquartered in Vienna, Austria.

How many employees does Apeiron Biologics have?

Apeiron Biologics has 35 employees.

What sector is Apeiron Biologics in?

Apeiron Biologics is a life science company.

When was Apeiron Biologics founded?

Apeiron Biologics was founded in 2006.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 184 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 170 by strategics.

Apeiron Biologics

Apeiron Biologics AG

Campus-Vienna-Biocenter 5,
Vienna, 1030
Austria,
+43 (0) 1 86565 77
www.apeiron-biologics.com

Apeiron Biologics is a private biopharmaceutical company that co-developed QARZIBA (dinutuximab beta), a high-risk neuroblastoma drug, which it licensed to EUSA Pharma (UK) Limited (now a Recordati S.p.A. company) in 2016. The company also maintains a portfolio of more than 400 patents including the intellectual property and licenses for an early-stage immuno-oncology portfolio currently being developed by invIOs Holding AG which was spun-off from APEIRON in 2022. Apeiron Biologics was formed in 2000 and is based in


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.0/yr) # 1 - - - - - 1
  1

Most Recent M&A

Company Date Value Type
Apeiron Biologics AG - Isqette (Dinutuximab Beta) 2016-10-04 - Divestiture
Langhorne, Pennsylvania
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science - - 1 (100%) -
Total - - 1 -

By Geo

State/Country Buy Value Sell Value
United States - - 1 -
  Pennsylvania - - 1 -
Total - - 1 -

M&A Connections

Deals
Divested to
Strategic(s)
100%
1 (100%)

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Apeiron Biologics

Life Science Companies , Austria Companies